"Battelle has tremendous technical and development capabilities in complementary areas to BTG. By joining forces, we will be able to accelerate the development of early stage technologies across a range of technology areas" said Geoffrey Porges, BTG's Chief Operating Officer, Europe.

"Bringing technology to the marketplace is Battelle's focus," said Doug Olesen, Battelle's President and Chief Executive Officer. "We're pleased to work closely with a company of BTG's calibre - an international leader in technology commercialization."

Battelle's Chief Financial Officer Mark Kontos added, "Battelle sees this collaboration as a tremendous opportunity to combine our technology development skills with BTG's unparalleled commercialization expertise. Together we can bring a wider array of innovative products to the market than either company could by itself."

For further information please contact: Mary Clark from BTG at +44 (0) 171 575 1671 or e-mail to mary.clark@btgplc.com; or Katy Delaney from Battelle at (614) 424-5544 or e-mail to delaneyk@battelle.org.

NOTES TO EDITORS

BTG

BTG is a global leader in patenting and marketing intellectual property for technologies that shape the future. BTG acquires, develops and licenses intellectual property covering innovative products and processes in the fields of electronics, engineering, and information technology, health, medical and biotechnology sciences.

With its headquarters in London and offices in Philadelphia and Tokyo, BTG capitalizes on a global network of contacts in companies, universities and research institutions to identify and commercialize the most promising technologies. Since its founding in 1949, BTG has commercialized such major innovations as magnetic resonance imaging (MRI), Interferon and wide-spectrum cephalosporin antibiotics.

BTG International Ltd and BTG International Inc. are wholly owned subsidiaries of BTG plc, which is quoted on the London Stock Exchange under the symbol "BGC". BTG's web site www.btgplc.com includes information about our business and recent press releases.

Battelle Memorial Institute

Battelle focuses on product development, technology development and commercialization. Its technological expertise has been a major factor in development of some of the world's most successful products-from the compact disc to breakthrough medical products to the office copier.

Battelle, headquartered in Columbus, Ohio, focuses on technology development and commercialization and product development. With 7,500 employees at more than 60 locations, Battelle develops technologies and products for industry and government. Annual revenues are approximately $1 billion. For more information on Battelle and its technology forecasts, visit Battelle's web site at www.battelle.org, or contact Katy Delaney, Media Relations manager, (614) 424-5544.